We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App





Bio-Rad Exhibits Range of Solutions for Maximizing Lab Efficiency at AACC

By LabMedica International staff writers
Posted on 26 Jul 2022

At the 2022 AACC Clinical Lab Expo, Bio-Rad Laboratories (Hercules, CA, USA) is presenting its range of solutions that support labs by maximizing efficiency through streamlining workflows, consolidating platforms, improving turnaround time and gaining confidence in results. More...



Bio-Rad is exhibiting its quality control solutions that help streamline workflows, reduce errors, maintain compliance, and facilitate accreditation—improving efficiency and saving money. These solutions included its InteliQ Load-and-Go Controls that can transform QC workflow with load-and-go-efficiency. InteliQ quality controls, a smarter way to manage QC, help automate workflow - reducing turnaround time, limiting manual errors, and increasing overall efficiency. Bio-Rad will also present its Unity QC Data Management Solutions that help achieve greater efficiency while reducing costs. In addition to identifying trends and making corrections before results are compromised, connectivity to the world’s largest community of QC users brings the confidence and reliability to stand behind the results. Also on display will be the company’s comprehensive line of molecular quality controls, standards, and data management solutions that streamline workflow and set a new standard in molecular lab performance.

Visitors at Bio-Rad’s AACC 2022 booth can experience its D-100 hemoglobin testing system, a fully automated, best-in-class HbA1c analyzer featuring a highly evolved combination of hardware, software and chemistry for high-volume labs, and the BioPlex 2200 System, which consolidates autoimmune, infectious disease, and vitamin D testing all on one fully automated, track line compatible, random-access platform. Also on display at the event will be IH-500, the latest addition to the Bio-Rad IH-Complete family of immunohematology testing systems that delivers an easy-to-use, fully automated system with random access and minimal user intervention. In addition, Bio-Rad is showcasing the IH-Reader 24, a combination centrifuge and reader for convenient and intelligent processing of manually pipetted IH-Gel Cards; the IH-1000 fully automated, walk-away system for ID-Cards with high-throughput, continuous sample and reagent loading; and the IH-Centrifuge L and IH-Incubator L, small but powerful members of the IH-Complete family that allow labs of all sizes to standardize gel and tube applications.
 

Related Links:
Bio-Rad Laboratories 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Thyroid Test
Anti-Thyroid EIA Test
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.